Form 4 Roivant Sciences Ltd. For: Nov 07 Filed by: Venker Eric
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Wall St set for mixed open ahead of SK Hynix listing; Middle East in focus
- Oil heads for weekly gains as Middle East supply risks persist
- The real reason Meta shares are surging has nothing to do with its new AI model
- Stifel lifts Shopify to Buy, sees agentic commerce as next growth catalyst
- Delta Air Lines stock climbs on earnings beat and strong guidance
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
Roivant Sciences (ROIV) PT Raised to $26 at Citi
November 10, 2025 3:58 PM ESTCiti analyst Samantha Semenkow raised the price target on Roivant Sciences (NASDAQ: ROIV) to $26.00 (from $25.00) while maintaining a Buy rating.
Removes 90-Day Upside Catalyst Watch... More